Osteonecrosis due to drugs, unspecified tibia
ICD-10 M87.163 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, unspecified tibia.
Osteonecrosis due to drugs, particularly affecting the tibia, is a condition characterized by the death of bone tissue due to a lack of blood supply, often precipitated by the use of certain medications. This condition can arise from various pharmacological agents, including corticosteroids, bisphosphonates, and chemotherapy drugs. The tibia, being a weight-bearing bone, is particularly susceptible to the effects of osteonecrosis, leading to pain, swelling, and potential joint dysfunction. Clinically, patients may present with localized pain that worsens with activity and may be accompanied by swelling or tenderness over the affected area. Imaging studies, such as MRI or X-rays, are essential for diagnosis, revealing characteristic changes in bone density and structure. Early intervention is crucial to prevent further complications, including the risk of fracture or the need for surgical intervention. Treatment options may include medication adjustments, physical therapy, or surgical procedures such as core decompression or joint replacement, depending on the severity of the condition.
Comprehensive documentation of patient history, including medication use, imaging results, and clinical findings.
Patients presenting with chronic pain in the tibia after prolonged corticosteroid use.
Orthopedic surgeons should ensure that all relevant imaging studies are included in the documentation to support the diagnosis.
Detailed records of systemic conditions and medications that may contribute to osteonecrosis.
Patients with autoimmune disorders on long-term immunosuppressive therapy presenting with bone pain.
Rheumatologists should document the rationale for medication choices and any changes in therapy.
Used for joint pain management in patients with osteonecrosis.
Document the indication for the procedure and the patient's response.
Orthopedic specialists should ensure that the procedure is justified based on clinical findings.
Common medications include corticosteroids, bisphosphonates, and certain chemotherapy agents. It is essential to document any history of these medications when coding for osteonecrosis.